Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Dermatologists are more accurate than general practitioners in diagnosing skin conditions, especially skin cancer.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Some drugs used to treat immune conditions may cause different types of hair loss.

Early recognition and treatment of tinea capitis are crucial to prevent severe scalp issues and prolonged therapy.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Pityriasis rubra pilaris is a rare skin disorder with reddish-orange patches and thickened skin, needing better treatment understanding.

Pityriasis amiantacea is likely linked to eczema-related skin changes.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

The summary does not report the effectiveness of Stanozolol in treating Pityriasis rubra pilaris.

Pityriasis rubra pilaris significantly worsens quality of life more than many other health conditions.

PRP patients show varied symptoms and need more research to understand related conditions.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Pityriasis amiantacea is a scalp condition with thick, greasy scales and sometimes hair loss.

The cause of the syndrome with scalp scaling and hair loss is unknown.

There may be a link between Helicobacter pylori infection and the skin condition pityriasis versicolor.

Dermoscopic and histopathological features combined can help diagnose Pityriasis versicolor.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

A woman developed a rare scalp condition after starting minoxidil, which was resolved with specific shampoo and solution.

A woman developed a hair disorder after a bone marrow transplant, which improved with treatment.

A boy's scalp infection, usually found on the body, was effectively treated with antifungal cream.

Dermoscopic features can help identify and differentiate types of pityriasis versicolor.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Seborrheic dermatitis and dandruff are often treated with antifungal and anti-inflammatory medications, which can reduce symptoms and yeast growth on the scalp.

A young boy with a rare skin and nail condition improved significantly with simple topical treatments.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

An 18-year-old woman was diagnosed with a rare skin condition called Pityriasis rubra pilaris.